• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类受试者重复口服一种复方制剂后,甲喹酮的血清浓度。

Serum concentrations of methaqualone after repeated oral doses of a combination formulation to human subjects.

作者信息

White C, Doyle E, Chasseaud L F, Taylor T

出版信息

Eur J Clin Pharmacol. 1976 Sep 30;10(5):343-7. doi: 10.1007/BF00565624.

DOI:10.1007/BF00565624
PMID:10165
Abstract

Concentrations of methaqualone have been measured in the serum of five male human subjects receiving five consecutive evening doses of a combination formulation containing methaqualone (250 mg), carbromal (300 mg) and benactyzine (0.33 mg) in each tablet. After administration of the first dose, mean peak serum concentrations of methaqualone (1.2 mug/ml) occurred at 3 h. After obtaining peak levels, mean concentrations of methaqualone declined rapidly during the next 6 h and thereafter more slowly during the next 18 h. After administration of the last (fifth) dose, mean peak serum concentrations of methaqualone (1.9 mug/ml; 1.5 mug/ml above the predose level) occurred at 2 h. After attaining peak levels, mean concentrations of methaqualone declined rapidly during the next 6 h, and thereafter more slowly, with a half-life of approximately 10 h. Mean concentrations of methaqualone in serum samples 24 h after the second, third, fourth or fifth doses were not significantly different (0.3 mug/ml - 0.6 mug/ml) during this period of dosing. This suggests that significant accumulation of methaqualone in the serum did not occur during a period of five consecutive evening doses of the combination formulation.

摘要

对五名男性受试者进行了研究,他们连续五个晚上服用了一种复方制剂,每片制剂含甲喹酮(250毫克)、溴米那(300毫克)和苯乃嗪(0.33毫克),并测定了血清中甲喹酮的浓度。服用首剂后,甲喹酮的血清平均峰值浓度(1.2微克/毫升)在3小时出现。达到峰值水平后,甲喹酮的平均浓度在接下来的6小时内迅速下降,之后在接下来的18小时内下降更为缓慢。服用最后一剂(第五剂)后,甲喹酮的血清平均峰值浓度(1.9微克/毫升;比给药前水平高1.5微克/毫升)在2小时出现。达到峰值水平后,甲喹酮的平均浓度在接下来的6小时内迅速下降,之后下降更为缓慢,半衰期约为10小时。在给药期间,第二、第三、第四或第五剂后24小时血清样本中甲喹酮的平均浓度无显著差异(0.3微克/毫升 - 0.6微克/毫升)。这表明在连续五个晚上服用该复方制剂期间,血清中甲喹酮未出现显著蓄积。

相似文献

1
Serum concentrations of methaqualone after repeated oral doses of a combination formulation to human subjects.在人类受试者重复口服一种复方制剂后,甲喹酮的血清浓度。
Eur J Clin Pharmacol. 1976 Sep 30;10(5):343-7. doi: 10.1007/BF00565624.
2
Methaqualone-diphenhydramine interaction study in humans.甲喹酮与苯海拉明在人体中的相互作用研究。
J Pharm Sci. 1983 Feb;72(2):176-80. doi: 10.1002/jps.2600720220.
3
Blood levels in methaqualone in man following chronic therapeutic doses.
Arch Int Pharmacodyn Ther. 1976 Aug;222(2):322-31.
4
Plasma levels and absorption of methaqualone after oral administration to man.口服甲喹酮后人体血浆中的药物水平及吸收情况。
Clin Pharmacol Ther. 1972 Sep-Oct;13(5):719-23. doi: 10.1002/cpt1972135part1719.
5
[Methaqualone--story about a sleeping medicine].[甲喹酮——一种安眠药的故事]
Lakartidningen. 1974 Oct 3;71(40):3777-80.
6
Plasma kinetics of methaqualone in man after single oral doses.单次口服剂量后甲喹酮在人体中的血浆动力学。
Eur J Clin Pharmacol. 1973 Oct;6(3):187-90. doi: 10.1007/BF00558284.
7
[Gas chromatographic determination of methaqualone in small amounts of serum after ingestion of therapeutic doses (author's transl)].治疗剂量摄入后血清中少量甲喹酮的气相色谱测定(作者译)
Arch Toxikol. 1973 Aug 30;31(1):25-30.
8
Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.一种新的格列美脲 1 毫克+二甲双胍 500 毫克复方片剂制剂与格列美脲 2 毫克+二甲双胍 500 毫克复方片剂制剂的药代动力学比较:一项在健康、禁食的韩国男性志愿者中进行的单次、随机、开放标签、两周期、两交叉研究。
Clin Ther. 2009 Nov;31(11):2755-64. doi: 10.1016/j.clinthera.2009.11.001.
9
Plasma concentrations and effects of methaqualone after single and multiple oral doses in man.甲喹酮单次及多次口服给药后在人体中的血浆浓度及效应
Eur J Clin Pharmacol. 1974 Oct 4;7(6):449-54. doi: 10.1007/BF00560357.
10
Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans.甲喹酮片在人体中的体外溶出度与体内生物利用度比较。
J Pharm Sci. 1978 Sep;67(9):1328-9. doi: 10.1002/jps.2600670940.

引用本文的文献

1
Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose.单次口服剂量后,人对甲喹酮代谢的个体间和个体内差异。
Eur J Clin Pharmacol. 1978 Jun 19;13(4):291-7. doi: 10.1007/BF00716365.
2
Clinical pharmacokinetics of hypnotics.催眠药的临床药代动力学。
Clin Pharmacokinet. 1977 Mar-Apr;2(2):93-109. doi: 10.2165/00003088-197702020-00002.

本文引用的文献

1
The influence of diphenhydramine on the absorption of methaqualone in man.多虑平对甲喹酮在人体内吸收的影响。
Br J Clin Pharmacol. 1974 Jun;1(3):259-64. doi: 10.1111/j.1365-2125.1974.tb00247.x.
2
Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man.从商业制剂中获取甲喹酮的可用性:人体的体外和体内研究。
Br J Clin Pharmacol. 1974 Apr;1(2):99-105. doi: 10.1111/j.1365-2125.1974.tb00217.x.
3
[HYPNOTIC PROPERTIES OF METHAQUALONE IN HEALTHY VOLUNTEERS].[甲喹酮在健康志愿者中的催眠特性]
Union Med Can. 1965 Mar;94:352-6.
4
Hypnotic action of methaqualone.甲喹酮的催眠作用。
Practitioner. 1963 Mar;190:368-70.
5
A clinical study of methaqualone: a new nonbarbiturate hypnotic.甲喹酮的临床研究:一种新型非巴比妥类催眠药。
Can Med Assoc J. 1961 Dec 9;85(24):1304-5.
6
Methaqualone as a hypnotic.甲喹酮作为一种催眠药。
Br Med J. 1961 Jan 21;1(5220):171-3. doi: 10.1136/bmj.1.5220.171.
7
Gas chromatographic determination of methaqualone, 2-methyl-3-o-tolyl-4(3H)-quinazolinone, at therapeutic levels in human plasma.气相色谱法测定人血浆中治疗浓度的安眠酮(2-甲基-3-邻甲苯基-4(3H)-喹唑啉酮)。
J Chromatogr. 1969 Jun 3;42(1):39-44. doi: 10.1016/s0021-9673(01)80585-9.
8
Metabolic fate of 2-methyl-3-o-tolyl-4(3H)-quinazolinone. I. 2-nitrobenzo-o-toluidide as an urinary metabolite of 2-methyl-3-o-tolyl-4(3H)-quinazolinone in human.
Chem Pharm Bull (Tokyo). 1970 Jan;18(1):133-7. doi: 10.1248/cpb.18.133.
9
Drug-metabolizing capacity in states of drug dependence and withdrawal.药物依赖和戒断状态下的药物代谢能力。
Br J Pharmacol. 1972 Aug;45(4):638-43. doi: 10.1111/j.1476-5381.1972.tb08122.x.
10
Plasma levels and absorption of methaqualone after oral administration to man.口服甲喹酮后人体血浆中的药物水平及吸收情况。
Clin Pharmacol Ther. 1972 Sep-Oct;13(5):719-23. doi: 10.1002/cpt1972135part1719.